dc.creator | Rojas, F A | |
dc.creator | Carvalho, C R | |
dc.creator | Paez-Espinosa, V | |
dc.creator | Saad, M J | |
dc.date | 2000-Jun | |
dc.date | 2015-11-27T12:22:43Z | |
dc.date | 2015-11-27T12:22:43Z | |
dc.date.accessioned | 2018-03-29T00:54:25Z | |
dc.date.available | 2018-03-29T00:54:25Z | |
dc.identifier | Iubmb Life. v. 49, n. 6, p. 501-9, 2000-Jun. | |
dc.identifier | 1521-6543 | |
dc.identifier | 10.1080/15216540050167043 | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/11032244 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/194604 | |
dc.identifier | 11032244 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1294837 | |
dc.description | Insulin induces phosphorylation and activation of JAK2 tyrosine, as well as its association with STAT1 and SHP2 in insulin-sensitive tissues of intact rats, thus demonstrating a new pathway in transduction of insulin signals. We investigated this pathway in hearts of rats in three situations of insulin resistance: 72 h of fasting, chronic treatment with dexamethasone, and acute treatment with epinephrine. The acute treatment with epinephrine showed no difference in insulin-induced JAK2 tyrosine phosphorylation or JAK2/STAT1 and JAK2/SHP2 association in comparison with the control. In fasted rats the JAK2 protein concentration decreased, accompanied by a decrease in the stoichiometry of the phosphorylation to 70%, an increase in association of JAK2/STAT1 to 160%, and a decrease in JAK2/SHP2 association to 85%. In the dexamethasone-treated group, the JAK2 protein concentrations increased but the stoichiometry of its phosphorylation decreased to 20%, whereas the JAK2/STAT1 and JAK2/SHP2 associations changed by 70% and 170%, respectively. In fasting and dexamethasone-treated rats, therefore, insulin-induced JAK2 tyrosine phosphorylation decreases, and the JAK2 protein expression is differentially regulated such that the insulin-induced JAK2 association with SHP2 and STAT1 shows opposite interactions with the kinase. | |
dc.description | 49 | |
dc.description | 501-9 | |
dc.language | eng | |
dc.relation | Iubmb Life | |
dc.relation | IUBMB Life | |
dc.rights | fechado | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Animals | |
dc.subject | Dna-binding Proteins | |
dc.subject | Dexamethasone | |
dc.subject | Enzyme Activation | |
dc.subject | Epinephrine | |
dc.subject | Fasting | |
dc.subject | Insulin Resistance | |
dc.subject | Intracellular Signaling Peptides And Proteins | |
dc.subject | Janus Kinase 2 | |
dc.subject | Male | |
dc.subject | Myocardium | |
dc.subject | Phosphorylation | |
dc.subject | Protein Tyrosine Phosphatase, Non-receptor Type 11 | |
dc.subject | Protein Tyrosine Phosphatase, Non-receptor Type 6 | |
dc.subject | Protein Tyrosine Phosphatases | |
dc.subject | Protein-tyrosine Kinases | |
dc.subject | Proto-oncogene Proteins | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Stat1 Transcription Factor | |
dc.subject | Signal Transduction | |
dc.subject | Trans-activators | |
dc.subject | Tyrosine | |
dc.title | Regulation Of Cardiac Jak-2 In Animal Models Of Insulin Resistance. | |
dc.type | Artículos de revistas | |